JP2025510948A5 - - Google Patents
Info
- Publication number
- JP2025510948A5 JP2025510948A5 JP2024557470A JP2024557470A JP2025510948A5 JP 2025510948 A5 JP2025510948 A5 JP 2025510948A5 JP 2024557470 A JP2024557470 A JP 2024557470A JP 2024557470 A JP2024557470 A JP 2024557470A JP 2025510948 A5 JP2025510948 A5 JP 2025510948A5
- Authority
- JP
- Japan
- Prior art keywords
- individually
- sequence numbers
- numbers
- sequence
- individually sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263326269P | 2022-03-31 | 2022-03-31 | |
| US63/326,269 | 2022-03-31 | ||
| US202263341681P | 2022-05-13 | 2022-05-13 | |
| US63/341,681 | 2022-05-13 | ||
| PCT/US2023/065233 WO2023193003A2 (en) | 2022-03-31 | 2023-03-31 | Cd4-specific antibody constructs and compositions and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025510948A JP2025510948A (ja) | 2025-04-15 |
| JP2025510948A5 true JP2025510948A5 (https=) | 2026-04-08 |
Family
ID=88203505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024557470A Pending JP2025510948A (ja) | 2022-03-31 | 2023-03-31 | Ｃｄ４特異的抗体構築物及び組成物ならびにその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250281536A1 (https=) |
| EP (1) | EP4499706A2 (https=) |
| JP (1) | JP2025510948A (https=) |
| KR (1) | KR20250005572A (https=) |
| CN (1) | CN119317642A (https=) |
| AU (1) | AU2023243626A1 (https=) |
| CA (1) | CA3255336A1 (https=) |
| IL (1) | IL315572A (https=) |
| WO (1) | WO2023193003A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024064838A1 (en) * | 2022-09-21 | 2024-03-28 | Sana Biotechnology, Inc. | Lipid particles comprising variant paramyxovirus attachment glycoproteins and uses thereof |
| CN118146376B (zh) * | 2024-05-09 | 2024-07-05 | 成都微芯新域生物技术有限公司 | Hla-g抗体及其制备方法和用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9005963B2 (en) * | 2008-10-14 | 2015-04-14 | Ablynx N.V. | Amino acid sequences directed against cellular receptors for viruses and bacteria |
| US11299751B2 (en) * | 2016-04-29 | 2022-04-12 | Voyager Therapeutics, Inc. | Compositions for the treatment of disease |
| AU2019222560B2 (en) * | 2018-02-17 | 2025-07-03 | Flagship Pioneering Innovations V, Inc. | Compositions and methods for membrane protein delivery |
| AU2019234183B2 (en) * | 2018-03-15 | 2025-12-18 | Biond Biologics Ltd. | Methods and compositions for decreasing soluble immune receptor CD28 |
| US12036242B2 (en) * | 2018-07-05 | 2024-07-16 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | CAR T cells that target B-cell antigens |
| EP4381081A1 (en) * | 2021-08-04 | 2024-06-12 | Sana Biotechnology, Inc. | Use of cd4-targeted viral vectors |
-
2023
- 2023-03-31 EP EP23782106.1A patent/EP4499706A2/en active Pending
- 2023-03-31 WO PCT/US2023/065233 patent/WO2023193003A2/en not_active Ceased
- 2023-03-31 IL IL315572A patent/IL315572A/en unknown
- 2023-03-31 US US18/852,220 patent/US20250281536A1/en active Pending
- 2023-03-31 AU AU2023243626A patent/AU2023243626A1/en active Pending
- 2023-03-31 JP JP2024557470A patent/JP2025510948A/ja active Pending
- 2023-03-31 CA CA3255336A patent/CA3255336A1/en active Pending
- 2023-03-31 KR KR1020247035855A patent/KR20250005572A/ko active Pending
- 2023-03-31 CN CN202380043231.8A patent/CN119317642A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024532963A5 (https=) | ||
| KR102946697B1 (ko) | 키메라 분자 및 그의 용도 | |
| JP2023060000A (ja) | レトロウイルスおよびレンチウイルスベクター | |
| JP7669327B2 (ja) | ナチュラルキラー細胞免疫療法における切断されたｎｋｇ２ｄキメラ受容体及びその使用 | |
| JP2025510948A5 (https=) | ||
| US11591613B2 (en) | Retroviral and lentiviral vectors | |
| JP5553989B2 (ja) | ウィルスベクターを使用した標的化遺伝子送達方法 | |
| WO2021178717A2 (en) | Improved methods and compositions for modulating a genome | |
| US20190169296A1 (en) | Targeting pd-l1 on tumor cells | |
| CN107708710A (zh) | Smart CAR装置,DE CAR多肽,Side CAR及其使用 | |
| JP2022513326A5 (https=) | ||
| CN117677633A (zh) | 基于nkg2d的嵌合抗原受体 | |
| CN120936364A (zh) | 修饰的弹状病毒糖蛋白及其用途 | |
| KR20240019811A (ko) | Gpc3 결합 분자 | |
| CN120302988A (zh) | 新型抗间皮素嵌合抗原受体和经修饰的免疫细胞 | |
| CA3255336A1 (en) | CD4-SPECIFIC ANTIBODY CONSTRUCTIONS AND ASSOCIATED COMPOSITIONS AND USES | |
| CA3230810A1 (en) | Gene sequence construct for gene therapy of human immunodeficiency virus infection | |
| JP2021529539A5 (https=) | ||
| CN106467576A (zh) | 一种抗体融合蛋白及其制备方法与应用 | |
| WO2023030312A1 (zh) | 一种用于艾滋病病毒感染基因治疗的基因序列构建体 | |
| Chiyyeadu | Antibody-based strategies for infectious diseases, regenerative medicine and cancer | |
| JP2025539364A (ja) | 遺伝子操作ｔ細胞 | |
| KR20250060244A (ko) | 조작된 외피보유 벡터 및 이의 사용 방법 | |
| JP2022507268A (ja) | 結合ドメインおよび分泌可能なペプチドの遺伝子を含む組換えベクター |